Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124693 · ClinicalTrials.gov registry record · NA
Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT03124693 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 90 participants.
The verdict
NCT03124693, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
In this study, the concentration of hemoglobin within the subject's blood is affected by fluid status changes. The fluid status is affected by fluid loss during surgery for hospitalized study subjects or controlled administration of fluids intravenously for healthy study volunteers. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparing with blood sample analysis.
Interventions
- DEVICE Rainbow DCI pulse oximeter sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-08-12 |
| Est. Completion | 2008-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03124693
The ClinicalTrials.gov registry entry for NCT03124693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rainbow DCI pulse oximeter sensor is the first listed.
NCT03124693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03124693 about?
NCT03124693 is a clinical study titled "Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor". In this study, the concentration of hemoglobin within the subject's blood is affected by fluid status changes. The fluid status is affected by fluid loss during surgery for hospitalized study subjects or controlled administration of fluids intravenously for healthy study volunteers. The accuracy of ...
What is the current status of trial NCT03124693?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-08-12. Estimated completion is 2008-09-09.
What interventions are being tested in trial NCT03124693?
The interventions under investigation include: Rainbow DCI pulse oximeter sensor (DEVICE).
Who is sponsoring clinical trial NCT03124693?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.